MENU
+Compare
NKTR
Stock ticker: NASDAQ
AS OF
May 14, 04:59 PM (EDT)
Price
$0.71
Change
-$0.00 (-0.00%)
Capitalization
132.13M

NKTR Nektar Therapeutics Forecast, Technical & Fundamental Analysis

Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy... Show more

Industry: #Biotechnology
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for NKTR with price predictions
May 13, 2025

NKTR's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for NKTR turned positive on May 13, 2025. Looking at past instances where NKTR's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NKTR's RSI Oscillator exited the oversold zone, of 43 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 70 cases where NKTR's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where NKTR advanced for three days, in of 238 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 123 cases where NKTR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on May 06, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on NKTR as a result. In of 82 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

NKTR moved below its 50-day moving average on May 05, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where NKTR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NKTR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.615) is normal, around the industry mean (14.420). P/E Ratio (0.000) is within average values for comparable stocks, (65.047). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.146). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (1.706) is also within normal values, averaging (254.920).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NKTR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
NKTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

NKTR is expected to report earnings to fall 30.33% to -16 cents per share on August 07

Nektar Therapeutics NKTR Stock Earnings Reports
Q2'25
Est.
$-0.17
Q1'25
Missed
by $0.08
Q4'24
Beat
by $0.19
Q3'24
Beat
by $0.02
Q2'24
Missed
by $0.06
The last earnings report on May 08 showed earnings per share of -23 cents, missing the estimate of -15 cents. With 667.60K shares outstanding, the current market capitalization sits at 132.13M.
A.I. Advisor
published General Information

General Information

a developer of inhalation drug delivery systems

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
455 Mission Bay Boulevard South
Phone
+1 415 482-5300
Employees
137
Web
https://www.nektar.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LIDRX9.31N/A
N/A
Lord Abbett International Value R2
FEYIX27.15N/A
N/A
Fidelity Advisor Asset Manager 85% I
LSVVX13.73N/A
N/A
LSV Conservative Value Equity
MFWBX17.52N/A
N/A
MFS Global Total Return B
KGROX11.88N/A
N/A
Kennedy Capital Small Cap Growth Instl

NKTR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTR has been loosely correlated with CRSP. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTR jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTR
1D Price
Change %
NKTR100%
-0.67%
CRSP - NKTR
48%
Loosely correlated
+4.49%
IPSC - NKTR
47%
Loosely correlated
+0.25%
RXRX - NKTR
45%
Loosely correlated
-2.80%
DNLI - NKTR
45%
Loosely correlated
-3.65%
PRME - NKTR
45%
Loosely correlated
-5.22%
More